Search Within
Document Type
1239-45-8
Keyword:'1239-45-8'
Showing 1-13 of 13 results for "1239-45-8" within Technical Documents
Anti-Calpain-5 (Domain II) Large Subunit antibody produced in rabbit (C1239)
(Domain II),
Large Subunit
Developed in Rabbit
Affinity Isolated Antibody
Product Number C 1239
Product Description
Anti-Calpain-5 (Domain II), Large Subunit is developed
in rabbit using
Quality Control Range Sheet- A6042-105 and A6042-205
Range Units
IL-12(p70) Control 1 270 – 561 pg/mL IL-7 Control 1 93 – 192 pg/mL
Control 2 1239 – 2573 pg/mL Control 2 479 – 995 pg/mL
TB042VM pET-11a-d Vector Map
1598 4743 4917
Enzyme # Sites Locations
BsrFI 8 160 495 504 871 2083
2243 2597 4762
BssHII 1 1596
Bst1107I 1 3560
BstEII 1 1366
BstXI 3 987 1116 1239
BstYI 11
Cac8I 42
CjeI 28
CjePI 26
ClaI 1 24
CviJI
MultiScreenHTS Filter Plates: New plate design for full automation compatibility
Bottom counting 1.4% 7.1% 5:1 36:1 6.7 7:1
MultiScreenHTS FC Coincidence counting 8.9% 14.9% 120:1 1239:1 25.1 28:1
MultiScreenHTS FC Top counting 8.5% 7.7% 3:1 4:1 21.7 4:1
MultiScreenHTS FC Bottom
Data Sheet - 74667
of
Candida albicans and other pathogenic Candida species. Infection and Immunity, 73
(2), pp 1239 – 1242, 2005
74667 Nourseothricin sulfate BioChemika
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
LIF IL-15 Myostatin FABP3 Irisin FSTL1 OSM IL-6 FGF21 Musclin
N 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Average 228 101 9548 1239 425343 10 3 8625 1943 495 6491
Calbiochem Biologics 29.2
Reacts with human and mouse. Ron is activated by phosphorylation at IB 10T
(Tyr1238/1239), Human (Rabbit) Tyr1238/1239.
* DB: dot blot; IB: immunoblotting; IC: immunocytochemistry; IF: immunofluorescence
App Note: Scalability Studies for Millistak+® HC and Millistak+® HC Pro Micro 20 Devices
Millistak+® HC Pro
D0SP 45
C0SP 40
X0SP 29
Table 3. Recommended maximum tubing lengths
for a Micro 20 device at the specified process flux.
Flux (LMH)
1/16-in. I.D. 1/8-in. I.D.
Max
MILLIPLEX®MAP metabolic hormones in human serum and plasma
hypoglycemic
clamp experiments in healthy volunteers. J Clin Endocrinol Metab.
2002 Mar; 87(3): 1239 – 46.
9. Broglio F, Gottero C, Prodam F, Destefanis S, Gauna C, Me E,
Riganti F, Vivenza D, Rapa
Applicaton Note: A new MILLIPLEX® map multiplex panel enhances simultaneous quantitation of metabolic hormones in human serum and plasma
stepped hypoglycemic clamp experiments
in healthy volunteers. J Clin Endocrinol Metab. 2002
Mar;87(3):1239-46.
9. Broglio F, Gottero C, Prodam F, Destefanis S, Gauna C, Me
E, Riganti F, Vivenza D, Rapa
Article: Selection of clarification methods for improved downstream performance and economics
the selec tion of primar y cell culture clarif ication technology. Biotechn Prog,
2013; 29(5); 1239–45. ht tp://dx.doi.org/10.1002/btpr.1776.
Reagents for peptide labeling & biomolecule conjugation
2,4-dinitrophenyl-L-lysine
NBC No.: 04-12-1239; CAS No.: 148083-64-1; C27H26N4O8; M.W.: 534.5
TLC: CHCl3:MeOH:AcOH (90:8:2), purity: ≥ 98.00%.
CH3CN:CHCl3:AcOH (8:1:1), purity: ≥ 98.00%.
HPLC: purity: ≥
XP725 Worksheet for Lot Number 071M4826
1232 7 2 4 8 PUMA bbc3 P4618
1233 7 2 5 1 PUMA bbc3 P4743
1234 7 2 5 2 PUMA bbc3 P4743
1235 7 2 5 3 Pyk2 P3902
1236 7 2 5 4 Pyk2 P3902
1237 7 2 5 5 AP2 beta